X0306 4 2020-05-05 0 0000896262 AMEDISYS INC AMED 0001543701 Ginn Scott G 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Financial Officer Common Stock 2020-05-05 4 M 0 9000 27.35 A 27664 D Common Stock 2020-05-05 4 S 0 2319 174.34 D 25345 D Common Stock 2020-05-05 4 S 0 1818 175.24 D 23527 D Common Stock 2020-05-05 4 S 0 4330 176.10 D 19197 D Common Stock 2020-05-05 4 S 0 400 177.45 D 18797 D Common Stock 2020-05-05 4 S 0 133 178.16 D 18664 D Common Stock 2714 I Through 401(k) Plan Stock Option (right to buy) 27.35 2020-05-05 4 M 0 9000 0.00 D 2019-05-01 2025-05-01 Common Stock 9000 2250 D The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.63 to $174.54, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.64 to $175.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.63 to $176.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.03 to $177.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. The information in this report is based on a plan statement dated as of March 31, 2020. On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock, subject to time-based vesting. 11,250 of the options vested on May 1, 2019, and the remaining 11,250 options vested on May 1, 2020. After the transactions reported in this Form 4, 2,250 of the options remain unexercised. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2020-05-07